Detalles de la búsqueda
1.
In vitro and ex vivo Measurement of Prophylactic Dabigatran Concentrations with a New Ecarin-Based Thromboelastometry Test.
Transfus Med Hemother
; 44(2): 100-105, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28503126
2.
A Matter of Caution: Coagulation Parameters in COVID-19 Do Not Differ from Patients with Ruled-Out SARS-CoV-2 Infection in the Emergency Department.
TH Open
; 5(1): e43-e55, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33564744
3.
Reversal of apixaban induced alterations in haemostasis by different coagulation factor concentrates in patients after hip or knee replacement surgery.
Blood Transfus
; 17(2): 157-162, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29757137
4.
QCM-D surpassing clinical standard for the dose administration of new oral anticoagulant in the patient of coagulation disorders.
Biosens Bioelectron
; 104: 15-20, 2018 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29294406
5.
In vitro reversal of supratherapeutic rivaroxaban levels with coagulation factor concentrates.
Blood Transfus
; 14(5): 481-6, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27177413
6.
Measurement and reversal of prophylactic and therapeutic peak levels of rivaroxaban: an in vitro study.
Clin Appl Thromb Hemost
; 20(7): 735-40, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23832064
7.
A calcium-containing electrolyte-balanced hydroxyethyl starch (HES) solution is associated with higher factor VIII activity than is a non-balanced HES solution, but does not affect von Willebrand factor function or thromboelastometric measurements--results of a model of in vitro haemodilution.
Blood Transfus
; 12(2): 260-8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24333074
8.
Sustained enhancement of residual platelet reactivity after coronary stenting in patients with myocardial infarction compared to elective patients.
Thromb Res
; 125(5): e190-6, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20116087
Resultados
1 -
8
de 8
1
Próxima >
>>